| Robert J Laflam, MD | |
|
1 Pillsbury St, Suite 202, Concord, NH 03301-3556 | |
| (603) 224-4776 | |
| (603) 228-2113 |
| Full Name | Robert J Laflam |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 1 Pillsbury St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669578589 | NPI | - | NPPES |
| 30003040 | Medicaid | NH | |
| 0104942Y0NH01 | Other | NH | ANTHEM BCBS |
| 10611 | Other | NH | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 8088 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Professional Association | 3375532435 | 55 |
| Concord Hospital Inc | 6103721790 | 462 |
News Archive
New research suggests guidelines on children's exposure to radio frequency waves from technology are confusing for parents.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
Performing surgery on a pregnant patient is a delicate matter. Risks to both mother and baby must be carefully weighed in every decision a surgeon makes. Recently, at the University of Texas Medical Branch at Galveston, a surgeon performed a groundbreaking robotic laparoscopic procedure on a 35-year-old pregnant patient whose cervix was too short to sustain a pregnancy.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 2 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
New research suggests guidelines on children's exposure to radio frequency waves from technology are confusing for parents.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
Performing surgery on a pregnant patient is a delicate matter. Risks to both mother and baby must be carefully weighed in every decision a surgeon makes. Recently, at the University of Texas Medical Branch at Galveston, a surgeon performed a groundbreaking robotic laparoscopic procedure on a 35-year-old pregnant patient whose cervix was too short to sustain a pregnancy.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 2 days ago
| Entity Name | Anesthesia Associates Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881791150 PECOS PAC ID: 3375532435 Enrollment ID: O20040512000620 |
News Archive
New research suggests guidelines on children's exposure to radio frequency waves from technology are confusing for parents.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
Performing surgery on a pregnant patient is a delicate matter. Risks to both mother and baby must be carefully weighed in every decision a surgeon makes. Recently, at the University of Texas Medical Branch at Galveston, a surgeon performed a groundbreaking robotic laparoscopic procedure on a 35-year-old pregnant patient whose cervix was too short to sustain a pregnancy.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Laflam, MD 1 Pillsbury St, Suite 202, Concord, NH 03301-3556 Ph: (603) 224-4776 | Robert J Laflam, MD 1 Pillsbury St, Suite 202, Concord, NH 03301-3556 Ph: (603) 224-4776 |
News Archive
New research suggests guidelines on children's exposure to radio frequency waves from technology are confusing for parents.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
Performing surgery on a pregnant patient is a delicate matter. Risks to both mother and baby must be carefully weighed in every decision a surgeon makes. Recently, at the University of Texas Medical Branch at Galveston, a surgeon performed a groundbreaking robotic laparoscopic procedure on a 35-year-old pregnant patient whose cervix was too short to sustain a pregnancy.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 2 days ago
Kathryn S Lemmon, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 105 B Eye Anesthesia Of Concord Pllc, Concord, NH 03301 Phone: 603-224-6503 | |
Nathanael A. Slater, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 | |
Dr. Victoria Kogan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 | |
Gregory F. Martin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 | |
Roman Plachinta, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Pillsbury St, Ste 202, Concord, NH 03301 Phone: 603-224-4776 Fax: 603-228-2113 | |
Dr. John M Riddell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St., Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 | |
Margaret A Pitts, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St., Concord, NH 03301 Phone: 603-789-9103 Fax: 603-227-7832 |